ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD

🌳Matureactive
09272823 · ltd · incorporated 2014-10-21
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
  • · Thesis: well-run, low negotiation leverage
🔒Estimated value
Upgrade to see
Turnover
year to Oct 2024
Net worth
book net assets
Opportunity
79/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
ALSO REGISTERED FOR
  • 74909Other professional, scientific and technical activities n.e.c.
  • 82990Other business support service activities n.e.c.
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 79/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: high (80/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 3 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (2 active, 3 linked, 3 with DOB)
90
Ownership & PSC
1 active PSC(s) of 2 total, 2 with control declared
90
Director network
2 connected companies via shared directors
51
Filing history
49 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
79/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Oct 2023Oct 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2024-10-312023-10-31
Average employees300500

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
1
filing
  • 1 confirmation-statement
Last 90 days
1
filing
  • 1 confirmation-statement
Last 180 days
1
filing
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (22 events)Click to expand
  1. 2025-06-23
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2024-07-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  3. 2023-08-09
    📄
    resolution
    resolution · RESOLUTIONS
  4. 2023-07-04
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  5. 2023-03-01
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  6. 2022-11-23
    📄
    capital-alter-shares-subdivision
    capital · SH02
  7. 2022-11-23
    📄
    capital-alter-shares-subdivision
    capital · SH02
  8. 2022-11-23
    📄
    resolution
    resolution · RESOLUTIONS
  9. 2022-11-23
    📄
    memorandum-articles
    incorporation · MA
  10. 2022-11-22
    📄
    memorandum-articles
    incorporation · MA
  11. 2022-11-22
    📄
    capital-name-of-class-of-shares
    capital · SH08
  12. 2022-03-08
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  13. 2021-07-16
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  14. 2020-08-27
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  15. 2019-11-20
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  16. 2019-11-19
    📄
    change-person-director-company-with-change-date
    officers · CH01
  17. 2019-11-19
    📄
    change-person-director-company-with-change-date
    officers · CH01
  18. 2014-11-06
    DUGGAL, Surinder Kumar resigned
    director
  19. 2014-10-21
    🏢
    Company incorporated
    As ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD
  20. 2014-10-21
    DUGGAL, Ajay, Dr appointed
    director
  21. 2014-10-21
    DUGGAL, Brigitte Sabine appointed
    director
  22. 2014-10-21
    DUGGAL, Surinder Kumar appointed
    director

Owner dependency

74/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Senior director age: Director aged approximately 59 — approaching natural succession window.
  • +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.

Succession & seller-readiness

51/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • secondaryFounder aged 58+: Senior director is approximately 59. Early succession window.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Ajay Duggal
Individual · British · DOB 11/1967 · age 59
5075%
75–100%board control75-100% shares · 75-100% voting · board control23/11/2017
1 historic (ceased) PSC
  • Dr Ajay Duggalceased 23/11/2017· 25-50% shares

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · DA postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
A'FURGATO LTD
12932199 · est 2020 · no financials extracted
5y
ACCOUNTANTS (DR) LTD
07574410 · est 2011 · no financials extracted
15y
ACCOUNTANTS OF LAVENHAM LIMITED
12198298 · est 2019 · no financials extracted
6y
ACCOUNTING FREEDOM LTD
08641168 · est 2013 · no financials extracted
12y
ACCOUNTING PRO LONDON LTD
11090926 · est 2017 · no financials extracted
8y
ACE BUILDING & QUALITY CONTROL LTD
14786991 · est 2023 · no financials extracted
3y
ACTIVE IMMIGRATION SOLUTIONS LIMITED
05537170 · est 2005 · no financials extracted
20y
ACTUS FCR SOLUTIONS LIMITED
11726107 · est 2018 · no financials extracted
7y
AD HIRE GROUP LTD
14749888 · est 2023 · no financials extracted
3y
ADAM UK LTD
04630586 · est 2003 · no financials extracted
23y
ADEFIOYE CONSULTANCY LIMITED
08173747 · est 2012 · no financials extracted
13y
ADONIQAM LTD
10635810 · est 2017 · no financials extracted
9y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2014-10-21
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

Onega House, 112 Main Road
Sidcup
DA14 6NE
England

Filing status

Accounts
Next due: 2026-07-31
Last made up to: 2024-10-31
Confirmation statement
Next due: 2027-06-07
Last: 2026-05-24

Officers (2 active · 1 resigned)

DUGGAL, Ajay, Dr
director · ~59y · appointed 2014-10-21
View their other companies + combined net worth →
Active
DUGGAL, Brigitte Sabine
director · ~58y · appointed 2014-10-21
View their other companies + combined net worth →
Active
DUGGAL, Surinder Kumar
director · ~89y · appointed 2014-10-21 · resigned 2014-11-06
Resigned

Click a director name to see their full track record across all companies.

Recent filings (49 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2026-06-02
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-06-23
confirmation-statement-with-updates
confirmation-statement · CS01
2025-06-03
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-07-31
confirmation-statement-with-updates
confirmation-statement · CS01
2024-05-31
resolution
resolution · RESOLUTIONS
2023-08-09
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-07-04
confirmation-statement-with-updates
confirmation-statement · CS01
2023-05-24
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-03-01
confirmation-statement-with-updates
confirmation-statement · CS01
2022-12-06
capital-alter-shares-subdivision
capital · SH02
2022-11-23
capital-alter-shares-subdivision
capital · SH02
2022-11-23
resolution
resolution · RESOLUTIONS
2022-11-23
memorandum-articles
incorporation · MA
2022-11-23
memorandum-articles
incorporation · MA
2022-11-22